TRANSPLANTATION OF KERATINOCYTES IN THE TREATMENT OF WOUNDS

被引:59
作者
MYERS, S
NAVSARIA, H
SANDERS, R
GREEN, C
LEIGH, I
机构
[1] MT VERNON HOSP, RESTORAT APPEARANCE & FUNCT TRUST, NORTHWOOD HA6 2RN, MIDDX, ENGLAND
[2] ROYAL LONDON HOSP, DEPT EXPTL DERMATOL, LONDON E1 1BB, ENGLAND
[3] NORTHWICK PK HOSP & CLIN RES CTR, NORTHWICK PK INST MED RES, HARROW HA1 3UJ, MIDDX, ENGLAND
关键词
D O I
10.1016/S0002-9610(99)80258-X
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Keratinocyte grafting can be used to treat acute traumatic and chronic nonhealing wounds, The keratinocyte sheets are fragile and clinical ''take'' is difficult to assess, especially as activated keratinocytes secrete many growth factors, which have effects on wound healing apart from take, We have developed animal models of grafting that allow us to examine factors influencing autologous keratinocyte graft take. Results show clearly that pretreatment of the wound bed with viable dermis greatly increases the take of keratinocyte grafts, DATA SOURCES: International literature, CONCLUSIONS: AS a greater understanding of the complex interactions of cell and matrix evolve, so will potential therapeutic maneuvers, not just in the field of cultured keratinocyte grafts, but clearly in that of benign tumors, for example, keloids, and that of oncology, There is now overwhelming evidence of the requirement for a dermal substitute for cultured keratinocyte autografts, and the sheer complexity of the situation demands that this should approximate live human dermis as closely as possible, The stumbling blocks relate to avoiding the risks of viral transmission, tissue matching of host and donor, providing early epithelial cover, and improving delivery systems for fragile keratinocyte grafts,
引用
收藏
页码:75 / 83
页数:9
相关论文
共 110 条
[1]
CHANGES IN KERATINOCYTE ADHESION DURING TERMINAL DIFFERENTIATION - REDUCTION IN FIBRONECTIN BINDING PRECEDES ALPHA-5-BETA-1-INTEGRIN LOSS FROM THE CELL-SURFACE [J].
ADAMS, JC ;
WATT, FM .
CELL, 1990, 63 (02) :425-435
[2]
FIBRONECTIN INHIBITS THE TERMINAL DIFFERENTIATION OF HUMAN KERATINOCYTES [J].
ADAMS, JC ;
WATT, FM .
NATURE, 1989, 340 (6231) :307-309
[3]
KINETICS OF WITHDRAWAL FROM THE CELL-CYCLE IN CULTURED HUMAN EPIDERMAL-KERATINOCYTES [J].
ALBERS, KM ;
TAICHMAN, LB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (02) :161-164
[4]
CYTOKINE MODULATION OF KERATINOCYTE CYTOKINES [J].
ANSEL, J ;
PERRY, P ;
BROWN, J ;
DAMM, D ;
PHAN, T ;
HART, C ;
LUGER, T ;
HEFENEIDER, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (06) :S101-S107
[5]
HUMAN KERATINOCYTES ARE A MAJOR SOURCE OF CUTANEOUS PLATELET-DERIVED GROWTH-FACTOR [J].
ANSEL, JC ;
TIESMAN, JP ;
OLERUD, JE ;
KRUEGER, JG ;
KRANE, JF ;
TARA, DC ;
SHIPLEY, GD ;
GILBERTSON, D ;
USUI, ML ;
HART, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :671-678
[6]
INJURY INDUCES INVIVO EXPRESSION OF PLATELET-DERIVED GROWTH-FACTOR (PDGF) AND PDGF RECEPTOR MESSENGER-RNAS IN SKIN EPITHELIAL-CELLS AND PDGF MESSENGER-RNA IN CONNECTIVE-TISSUE FIBROBLASTS [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
KIRITSY, CP ;
LYNCH, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :565-569
[7]
KELOID FIBROBLASTS EXHIBIT AN ALTERED RESPONSE TO TGF-BETA [J].
BABU, M ;
DIEGELMANN, R ;
OLIVER, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (05) :650-655
[8]
BARLOW Y, 1992, J TISSUE VIABILITY, V2, P33
[9]
CELL-MIGRATION IS ESSENTIAL FOR SUSTAINED GROWTH OF KERATINOCYTE COLONIES - THE ROLES OF TRANSFORMING GROWTH FACTOR-ALPHA AND EPIDERMAL GROWTH-FACTOR [J].
BARRANDON, Y ;
GREEN, H .
CELL, 1987, 50 (07) :1131-1137
[10]
BASILE ARD, 1982, PLAST RECONSTR SURG, V69, P969, DOI 10.1097/00006534-198206000-00010